Imfinzi 500mg/10ml Injection 1s (Vial)

Imfinzi 500mg/10ml Injection contains Durvalumab as its active ingredient, an immunotherapy medication belonging to the checkpoint inhibitor class, used within specialised oncology treatment plans under close medical supervision. If this has been prescribed for you, it's helpful to know that commonly reported side effects include fatigue, cough, diarrhoea, or skin rash, along with the possibility of immune-related reactions affecting various organs that your care team will monitor closely. Because this is an infusion-based immunotherapy, it is administered exclusively by trained healthcare professionals in a clinical setting. Your oncology team will typically conduct regular blood tests and health assessments throughout treatment to monitor your safety and response. Prompt reporting of any new symptoms to your care team is an essential part of your treatment journey.

Dosage is individually determined by your oncologist based on your specific treatment protocol, generally administered once every four weeks. Your treatment schedule and dose will be determined and adjusted solely by your specialist care team.

• Fatigue
• Cough
• Diarrhoea
• Skin rash or itching
• Immune-related inflammation of organs requiring monitoring
• Fever
• Decreased appetite
• Abdominal pain
• Thyroid function changes
• Shortness of breath

This injection requires refrigerated storage between 2°C and 8°C and must be protected from light, with specific cold-chain handling maintained throughout transport and storage. Storage and handling of this product are managed by licensed pharmacy and healthcare professionals in line with strict clinical protocols.

• Attend all scheduled infusion appointments and follow-up assessments
• Report any new or unusual symptoms to your care team promptly, even if mild
• Inform your care team of any autoimmune conditions before starting
• Carry information about your immunotherapy treatment with you
• Maintain open communication about all symptoms throughout treatment
• Keep a record of all medications and supplements for your care team
• Discuss any planned vaccinations with your oncology team in advance

Imfinzi is administered as an intravenous infusion by a qualified healthcare professional in a hospital or specialised infusion centre, generally given every four weeks as part of your treatment plan. This medication is not self-administered at home. Always follow the treatment schedule set out by your oncology care team.

Imfinzi Injection vials typically have a shelf life of around 24 months from the date of manufacture when stored correctly and unopened. This product's expiry is verified by the pharmacy and clinical team prior to administration.

The active ingredient is Durvalumab 500mg/10ml, a monoclonal antibody immune checkpoint inhibitor.

This medication should not be used by individuals with a known hypersensitivity to durvalumab. It requires careful evaluation by an oncologist in individuals with pre-existing autoimmune conditions or those who have undergone organ transplantation, given the immune-modulating mechanism of this therapy. This treatment is not intended for use during pregnancy or breastfeeding, and your oncology team will discuss suitability based on your full medical history.

Durvalumab may interact with corticosteroids and other immunosuppressive medications, which can reduce its effectiveness, so your care team will carefully review all current medications. There are no major specific food interactions. Always keep your full medication list updated with your oncology team throughout treatment.

Can Imfinzi Injection be sourced for Singapore-based patients through your Malaysia pharmacy?
This is a specialised immunotherapy infusion medication administered exclusively in a clinical setting. Please contact our team directly to discuss availability and coordination with your treating hospital or clinic.

Is a prescription required to purchase this medication?
Yes, this is a specialist oncology medication requiring a valid prescription and close coordination with your treating oncologist and clinical team.

How is authenticity verified for a specialised immunotherapy medication like this?
This product is sourced directly from verified manufacturers and authorised distributors, with full batch traceability and documentation provided to the dispensing clinical facility.

How does delivery work for a cold-chain injectable medication like this?
Given its temperature-sensitive nature, this product requires specialised cold-chain logistics coordinated directly between our pharmacy and the receiving clinical facility.

Is it safe to source specialist immunotherapy medication through a Malaysia-based pharmacy?
Yes, when coordinated properly between licensed pharmacies and your treating medical team, cross-border sourcing of specialist medication follows strict regulatory and clinical safety protocols.

Can this medication be shipped directly to a patient's home in Singapore?
No, this infusion medication must be administered by healthcare professionals in a clinical setting and cannot be self-administered or delivered directly to a residential address.

How can I coordinate an order for this medication with my treating hospital?
Please contact our customer support team directly so we can assist with coordinating your order alongside your treating oncology team's requirements.

What should happen if there are concerns about the product's condition upon receipt by the clinical facility?
Any concerns regarding product condition should be raised immediately between the receiving pharmacy or clinical facility and our supply team for prompt resolution.

Is patient information kept confidential throughout this process?
Yes, we adhere to strict data privacy and confidentiality standards for all patient and prescription information throughout the coordination and supply process.